Page 179 - Programme book for The International Liver Congress 2015, EASL ILC 2015

P0341 DECREASING MORTALITY BY LIVER DISEASES BUT ePOSTERS
P0342 INCREASING INCIDENCE OF AND MORTALITY BY
P0343 HEPATOCELLULAR CARCINOMA IN A HEPATITIS B VIRUS
P0344 ENDEMIC AREA: NATIONWIDE WHOLE POPULATION DATA
P0345 ANALYSES
P0346 Young-Suk Lim*,Yongjun Chang, Jihyun An, Namkug Kim, South Korea

CANCER STEM CELLS AND VASCULOGENIC MIMICRY
IN HEPATITIS C VIRUS-RELATED HEPATOCELLULAR
CARCINOMA: RELATION TO TUMOR PROGRESSION
Hoda El Aggan*, Layla Younis, Ehab Hassona, Mohamed Sharaan,
Walid Youssef, Egypt

THE PATTERN OF ALPHA-FETOPROTEIN LEVEL
HAS GREATER DIAGNOSTIC VALUE COMPARED TO
ISOLATED VALUES IN PREDICTING THE PRESENCE OF
HEPATOCELLULAR CARCINOMA
Abhinav Vasudevan, John Lubel*, Natalie Denyar, Kumanan Nalankilli,
Anvesh Jackson, Jarrod Greenhalgh, Cian Scanlon, Australia

STREAMLINING HEPATOCELLULAR CARCINOMA
SURVEILLANCE TO IMPROVE ITS PERFORMANCE: THE
HEPATOMA AND COMPENSATED CIRRHOTIC FOLLOW-UP
(HACC-FOL) PILOT PROGRAMME
Olivia Cullen*, Dilum Ekanayake, Mary Fenech, Karen Beckman,
Barbara Leggett, Richard Skoien, Australia

THE ROLE OF CYTOKINES AND SEROMARKERS
IN PREDICTING HCC RECURRENCE AFTER
RADIOFREQUENCY ABLATION—INTERIM REPORT
Wen-Juei Jeng, Wei-Ting Chen, Chen-Chun Lin, Chien-Hao Huang,
Wei Teng,Yi-Cheng Chen, Chao-Wei Hsu, Chun-Yen Lin, Shi-Ming Lin*,
Taiwan

MULTICENTER ANALYSIS OF SOLUBLE AXL REVEALS
DIAGNOSTIC VALUE FOR VERY EARLY STAGE
HEPATOCELLULAR CARCINOMA
Patrick Reichl, Meng Fang, Patrick Starlinger, Katharina Staufer,
Rudolf Nenutil, Petr Muller, Kristina Greplova, Dalibor Valik,
Steven Dooley, Christine Brostjan, Thomas Gruenberger,
Jiayun Shen, Kwan Man, Michael Trauner, Jun Yu, Chun Fang Gao,
Wolfgang Mikulits*, Austria

Vienna, Austria • April 22–26, 2015 179